Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 96,400
-5,600 (-5.49%)
Last updated: Feb 26, 2026, 9:52 AM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 758.46 billion as of February 25, 2026.
Market Cap
758.46B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
96,400.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 758.46B, an increase of 237.75%. That is a compound annual growth rate of 12,406.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 765.15B | 96.00% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.66T |
| HK inno.N | 1.62T |
| Myung In Pharmaceutical LTD. | 946.08B |
| ImmuneOncia Therapeutics | 628.18B |
| HEM Pharma | 574.46B |
| CellBion | 396.49B |
| DAE HWA Pharmaceutical | 267.65B |
| NOVAREX | 261.64B |